This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Drug Enforcement Administration (DEA) will move to reclassify cannabis — a historic shift that could have wide ripple effects across the country. What could the implications be for patients on their medical cannabis journey? What does rescheduling cannabis mean for medical cannabis patients? What does rescheduling actually mean?
Photo Credit: iStock With first-line recommended mental health interventions for PTSD treatment failing to eliminate symptoms in an average of 40% of patients in clinical studies, finding alternative effective and accessible treatments for PTSD is an urgent task from both an economic and public health standpoint.
ASA has recently revamped our Member Benefits Program, adding new benefits for our members each month like the 20% off offer on Nectar Products (see article below on Nectar) & 50% off registration for the upcoming Validated Voices Summit in September. A Patient & Consumer Guide to Navigating Cannabis Safety.
The FDA refers to this program as the expanded access program on their website. While they offer approved clinical trials that can offer patients the ability to try potential therapeutic options, many patients are unable to participate in clinical trials, and this is where the importance of the Right to Try programs comes into play.
is pleased to launch its proprietary and trademarked Tested Safe Certified Seal program, which is endorsed by the American Cannabinoid Association. BOCA RATON, Fla. , Aug. 24, 2021 /PRNewswire/ — ACS Laboratory , the largest state-of-the-art testing facility in cannabis and hemp testing in the eastern U.S.,
Although this is exciting for many advocates of the plant, many patients that are suffering from ailing health conditions are left wondering what this means for them, and how exactly all of these changes will impact their healthcare options. There is no universal handbook for a medical cannabis program. Check it out here.
Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. Circuit), a pending petition for review of DEA’s August 2020 Interim Final Rule purportedly implementing the 2018 Farm Bill’s amendments to the CSA.
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA. More CBD Coverage.
The successes of cannabis businesses are now a part of the mainstream conversation and considered big business, while the rights and protections for medical cannabis patients have been sidelined. So while a cannabis business can join their local chamber of commerce, a patient in hospice can be denied access to medical cannabis.
His findings are sure to alarm medical cannabis professionals and patients alike. As such, universities such as McMaster University and McGill University , among others, have built dedicated and comprehensive research programs. Drug Enforcement Agency (DEA) announced that it will evaluate 37 additional grower applications.
Despite the federal illegality of cannabis, lawmakers and state representatives have implemented successful medical and recreational cannabis programs across the nation. With legalization, patients and consumers have more freedom in product choice, and many are turning to homegrown cannabis. Cultivation Costs for Homegrowers.
he Alabama State Board of Medical Examiners Thursday announced draft rules to govern how physicians can recommend medical cannabis to eligible patients. The draft rules would require physicians to obtain an annual certification permit from the Alabama Board of Medical Examiners if they want to recommend a patient to use medical cannabis.
He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. Drug Enforcement Agency (DEA). territories. This means that U.S. federal law.
Drugs, substances, and certain chemicals used to make drugs are classified into five categories (known as schedules ) depending on the Department of Drug Enforcement Agency (DEA)’s definition of the drug’s acceptable medical use and abuse/dependency potential. ”, our first instinct is to remain patients that CBD is CBD.
The Act aimed to provide patients access to smokable flower for 15 medical conditions. This progressive legislation, once implemented, means a brand new slew of patients will have access to cannabis medicine. Wisconsin Wisconsin has no state medical cannabis program and no licensed medical Marijuana dispensaries.
However, given rapidly evolving – and often complicated – laws surrounding medical marijuana, many patients feel overwhelmed. In practice, the chances of feds or the DEA sitting at the border waiting to catch someone – that’s just not happening. Visiting Qualifying Patients. Planning a vacation should be fun.
Hawaii House Approves Proposal For Cannabis Exemption From DEA. Hawaii lawmakers approved Wednesday a proposal that seeks an exemption from Drug Enforcement Administration (DEA) regulations, asking that the state is allowed to manage its medical cannabis program without federal involvement, reported Marijuana Moment.
Lawmakers wrestled with the issue of capping THC content in medical marijuana for those patients under the age of 21. They see legalization as a solution to problems with the medical cannabis program. The Department of Agriculture delayed a requirement that the DEA conduct all THC testing on hemp crops. FEDERAL NEWS.
Cannabinoid Hemp Program Regulations (Finally) Finalized. While much attention is focused on New York’s adult-use cannabis market, the CCB and Office of Cannabis Management (OCM) are also responsible for overseeing both the Medical Marijuana and Cannabinoid Hemp Programs.
Outdated practices and a patchwork of laws create a legal minefield for medical patients to navigate in particular. A great example of this can be found in Pennsylvania with the case of medical cannabis patient Patrick Murphy. MMJ Patients Criminalized Despite Legality.
The new drug is indicated for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome. The Next Move Is On The DEA.
A recommendation from a physician is simply permission (‘recommendation’) for the patient to use cannabis, which can be obtained in any state where medical marijuana is legal. Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019.
The DEA sends a letter to Georgia pharmacies. GEORGIA Earlier this fall, we noted that independent pharmacies in Georgia would begin offering low THC oil to medical marijuana patients. Well, apparently the Drug Enforcement Administration (DEA) noted that as well, and they didn’t take kindly to it.
According to the Drug Enforcement Administration (DEA) website , magic mushrooms are recognizable by their slender stems, which are “topped by caps with dark gills on the underside.” Once consumed—whether fresh or dried in the form of a brewed tea or an edible—this hallucinogenic chemical transforms into psilocin.
We note that New York’s cannabis licensing program is facing yet another lawsuit. UNITED STATES ATTORNEYS Attorney General Merrick Garland and DEA Administrator Anne Milgram received a letter this week from several former United States Attorneys. And we check in on Virginia – how’s that retail market coming along?
Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. Right to Try laws permit patients with serious or life-threatening diseases to access drugs that do not yet have government approval.
D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted. Many of these medical conditions are featured on the list of qualifying criteria for medical cannabis programs in the 37 U.S.
The illicit extraction operation was detected by OLCC inspectors at an out-of-compliance Oregon Medical Marijuana Program (OMMP) medical grow site. Inspectors from the OLCC OMMP Marijuana Tracking Program were making a proactive check on the Lane County location which had been registered as an OMMP (GSA) grow site.
Earl Blumenauer, D-Oregon, would allow VA health providers to recommend medical marijuana to their veteran patients and fill out the necessary paperwork for them to enroll in state marijuana programs. One, the Veterans Equal Access Act, H.R. 1647, sponsored by Rep. Full story at [link].
Governor Polis is being faced with a lawsuit over House Bill 1317, a bill that negatively affected students who were meant to benefit from the law that allows cannabis use by medical patients in public schools. . There will also be expanded tracking on purchases, and limited purchases, even for medical cannabis patients. .
Things have changed a little in the past twenty years, when the DEA gave some researchers permission to study limited amounts of certain psychedelics. But they remain relatively small, in part because the DEA limits the amount of psilocybin and other psychedelics that can be produced each year. So far, that’s questionable.
House Republicans supported her proposal to defund the DEA and divert those funds to opioid treatment programs. . Patients in Virginia have been waiting and waiting for this day and it’s finally here! Patients in Virginia have been waiting and waiting for this day and it’s finally here! .
House Republicans supported her proposal to defund the DEA and divert those funds to opioid treatment programs. . Patients in Virginia have been waiting and waiting for this day and it’s finally here! Patients in Virginia have been waiting and waiting for this day and it’s finally here! .
Powered by Sail, we are on a mission to solve the issue of cannabis access for patients. We’re passionate about improving our patient’s quality of life and bringing cannabis into mainstream healthcare. Evaluate patient for verification of a qualifying condition. WE ARE SEEKING LICENSED MD OR ARPNs for our Hartford, CT clinic.
2 3 As clinical trials around the world proceeded in the late 1960s and 1970s, patients began reporting difficulty tolerating ketamine’s unpleasant hallucinogenic and dissociative properties. It was also after the Vietnam War that widespread ketamine abuse would begin to show up as a party drug. 9 How is ketamine commonly used?
The informed patients, cannabis industry employees, and clinicians find it equally difficult to keep updated on Florida’s latest medical marijuana program news and changes. . Patient and physician are on this rocky journey together, for better or worse. . “People do not know what’s going on.
The grant comes from Michigan’s 2021 Veteran Marijuana Research Grant Program , and is funded by the state’s recreational cannabis taxes. This trial will be the second of its kind to be conducted so far, and one that is an FDA- and DEA-regulated double-blind, placebo-controlled study. The study was funded with $2.2
Not long ago we wrote about a decision by the Second Circuit that may force the DEA to re- or deschedule marijuana after writing about the lawsuit when it was first filed last year. IDEA requires that schools provide special education services as outlined in a student’s Individualized Education Program (“IEP”).
Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. The MDMA Therapy Training Program was created to train the next generation of psychedelic therapists. Lyle Craker, Ph.D., Reddit awarded $82,765.95
Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma. This agency oversees licensing, regulation, and administration of the program. Other states have a list of conditions that the patients must meet to get an MMJ. Will I Be Put on a List?
Who Monitors This Program in Oklahoma? The Oklahoma Medical Marijuana Authority (OMMA) manages the MMJ program for the State of Oklahoma. This agency oversees licensing, regulation, and administration of the program. Other states have a list of conditions that the patients must meet to get an MMJ. Will I Be Put on a List?
Sue Sisley received for her study surrounding cannabis and PTSD was described as a “homogeneous green dust,” having no resemblance whatsoever to what is available for patients and consumers nationwide and in regulated markets. Lyle has been seeking authorization to become a federally licensed cannabis cultivator since 2001.
1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. Previously, such patients were limited to only non-smokable preparations of marijuana (such as gummies) and cannabis preparations administered via “metered-dose inhaler.”. Louisiana: As of Jan. California: As of Jan.
As of now, this is still a proposal, and it’s anyone’s guess if the DEA (who would do the actual re-scheduling) will think that’s a good idea. In October , independent pharmacies in Georgia registered with the Georgia Board of Pharmacy to provide low THC oil to medical cannabis patients. But what about federal legislation ??
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content